(ABT:New York Consolidated)
Transactions by ABBOTT LABORATORIES (ABT) in the last 6 months
Abbott Laboratories (NYSE:ABT) acquired UNeLAB from Prairie Ventures, LLC and other shareholders effective December 24, 2014.
Insight Realty Co., Pearlmark Real Estate Partners and Kinship Capital acquired 5301 Patrick Henry Drive in Santa Clara from Abbott Laboratories (NYSE:ABT) on December 19, 2014.
Pearlmark Real Estate Partners
Abbott Laboratories (NYSE:ABT) signed an agreement to acquire Topera, Inc. from Alafi Capital Company LLC, New Enterprise Associates and others for approximately $250 million in cash on October 29, 2014. Under the terms of the agreement Abbott will pay $250 million upfront, plus potential future payments tied to performance milestones. The deal is subject to customary closing conditions, including antitrust clearance. It is expected to close in the fourth quarter of ...
New Enterprise Associates
Abbott Laboratories (NYSE:ABT) announces a share repurchase program. Under the program, the company will repurchase up to $3,000 million worth of its shares. The repurchases may be made from time to time as market conditions warrant and subject to regulatory considerations. The company aims to return value to shareholders.
The Board of Directors of Abbott Laboratories has authorized a buyback plan on September 11, 2014.
On September 11, 2014, the company initiated ...
|AbbVie Inc||$60.50 USD||-0.02|
|Actavis plc||$291.36 USD||+1.58|
|Danaher Corp||$87.28 USD||-0.53|
|Eli Lilly & Co||$70.17 USD||+0.14|
|Teva Pharmaceutical Industries Ltd||$57.02 USD||+0.53|
|View Industry Companies|